Similar Posts
Smart home support
Technology company CareSmart is marketing Connected Care, which supports people with social care needs to live independently in their own homes. Connected Care kits include what the company describes as discreet activity sensors that can be placed around the home and are connected to a central 4G hub to check that the person is going…
Study shows faster MRI scans could be used to diagnose dementia
University College London (UCL) has published a study, part funded by Alzheimer’s Society’s Heather Corrie Impact Fund, that has shown shorter MRI scans (one third of the standard length) could be used to diagnose dementia. The team behind the ADMIRA study (Accelerated Magnetic Resonance Imaging for Alzheimer’s disease) scanned 92 people in an outpatient setting…
Reminiscence training
Expert training in reminiscence arts in dementia care is to be held at the University of Greenwich over two days later this month. Scheduled for 19 and 20 January, the experiential course will be led by experienced practitioners and trainers with input from volunteers and former carers. It will be certificated by the European Reminiscence…
Study links physical fitness with dementia risk-reduction
A study published in the British Journal of Sports Medicine has linked higher levels of cardiorespiratory fitness (CRF) to dementia risk-reduction. The research, undertaken by a Swedish team led by Prof Weili Xu of the Ageing Research Centre at the Karolinska Institute in Stockholm, analysed the health of 61,214 people who were aged between 39…
Magic Me publish their Annual Report
Magic Me, an arts charity that brings generations together, has published their annual report 2023/24 entitled: ‘Creativity, Connection and Growth’. Magic Me began in 1989 with a focus on intergenerational arts practices and arts initiatives for people living and working in care settings. In their latest Annual Report, Magic Me talk about ‘Spark’ (formerly Magic Moments)…
Alzheimer Scotland propose new assessment process after latest Scottish Medicines Consortium rejection of donanemab
Alzheimer Scotland has proposed a new assessment process after the Scottish Medicines Consortium reviewed further evidence on donanemab and continued to reject its use by NHS Scotland. Henry Simmonds, Alzheimer Scotland’s Chief Executive, says: “This demonstrates the urgent need for change in the system used to assess dementia drugs if we have any hope of…
